🇺🇸 FDA
Patent

US 10894816

Use of IL-15 to increase thymic output and to treat lymphopenia

granted A61KA61K38/00A61K38/1793

Quick answer

US patent 10894816 (Use of IL-15 to increase thymic output and to treat lymphopenia) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/1793, A61K38/2086, A61K45/06